Startup Daily

Eyes of AI to lead $6.7m project to speed up gum disease screening

Sydneyโ€™s Eyes of AI has secured a $2.2m CRC-P grant toward a $6.7m project to build Perio-Detect, an AI-powered, contactless periodontal screening tool with Data61 and the University of Sydney.
Sydney medtech startup Eyes of AI has secured a $2.2 million federal grant toward a $6.7 million project to build Perio-Detect, an AI-powered, contactless screening tool for periodontitis.

Partners include CSIROโ€™s Data61, the University of Sydney, and 3Shape Australia with the project running until 30 April 2028.

“This CRC-P selection is a major milestone for Eyes of AITM and for dental innovation globally,” said Eyes of AI CEO Khoa Le.

“Periodontitis is a silent epidemic affecting hundreds of millions worldwide. Our goal is to ensure that an Australian innovation can set a new global standard empowering clinicians everywhere with smarter tools and giving patients a better future.”

Periodontal disease affects up to half the worldโ€™s population and around six million Australians. Severe cases are linked to higher risks of cardiovascular disease, diabetes and dementia.

It’s a disease still typically checked with slow, uncomfortable tooth-by-tooth probing, an approach that can miss early warning signs

Perio-Detect is intended to replace that procedure with a contactless workflow fusing routine dental imaging and patient data. Eyes of AIโ€™s models aim to return an objective, trackable result in seconds.

Eyes of AI and its partners will focus early on clinical validation and regulatory pathways — work that, if successful, could shift periodontal care from reactive treatment to proactive prevention in Australian clinics first before moving internationally.

The company launched its rapid x-ray analysis in 2022 after three years of development.

Round 17 of the Cooperative Research Centres Projects grants awarded 21 projects more than $50.4 million in total government funding. CRC-P grants provide matched funding of $100,000โ€“$3 million for up to three years.